Market Analysis-Pharmaceutical Nanotechnology & NanomedicineAuthor(s): Masaki Otagiri
Universal Market for Nanotechnology products was evaluated $22.9 billion in 2013 and unanticipated grow to about $26 billion in 2014. This market is await to reach about $64.2 billion by 2019; a compound annual growth rate (CAGR) is 19.8% from 2014 to 2019. The global market for nanotechnology-enabled printing technology was approximate to be at total $14 billion in 2013. The market is anticipate to grow at a compound annual growth rate (CAGR) of 17.7% over the next five years and to total $31.8 billion by 2018. Nanomedicine is one of the utilizations of nanotechnology utilized in conclusion, treatment, observing, and control of natural frameworks. Nanomedicine utilizes nanoscale control of materials to improve medication conveyance. In this manner, nanomedicine has encouraged the treatment against different sicknesses. Nanomedicine is in early stage, as a few items are in the improvement stage. As indicated by Nanobiotix (a nanomedicine organization), in 2015, around 230 nanomedicine items were recognized, which are either checked or are in the preliminary stage. Also, according to the organization, there are 49 nanomedicine items in the market, though 122 items are in the clinical pipeline either in Phase II or Phase III preliminaries.